These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8863629)

  • 41. Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
    Tiguert R; Bianco FJ; Oskanian P; Li Y; Grignon DJ; Wood DP; Pontes JE; Sarkar FH
    J Urol; 2001 Dec; 166(6):2155-60. PubMed ID: 11696726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
    Salinas-Sánchez AS; Lorenzo-Romero JG; Giménez-Bachs JM; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-Del-Campo A; Hernández-Millán IR; Segura-Martín M; Atienzar-Tobarra M; Escribano-Martínez J
    Urol Oncol; 2008; 26(6):620-6. PubMed ID: 18367096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic implications of p53 gene mutations in bladder tumors.
    Lorenzo-Romero JG; Salinas-Sánchez AS; Giménez-Bachs JM; Sánchez-Sánchez F; Escribano-Martínez J; Segura-Martín M; Hernandez-Millán IR; Virseda-Rodríguez JA
    J Urol; 2003 Feb; 169(2):492-9. PubMed ID: 12544295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer.
    Lebret T; Becette V; Barbagelatta M; Hervé JM; Gaudez F; Barré P; Lugagne PM; Botto H
    J Urol; 1998 Mar; 159(3):788-91. PubMed ID: 9474149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical examination for p53 overexpression in Ta bladder cancer with disease progression].
    Tsukamoto T; Fujioka T; Nakano H; Takanashi K
    Hinyokika Kiyo; 1996 May; 42(5):347-9. PubMed ID: 8752536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
    Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C
    Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.
    Wright C; Thomas D; Mellon K; Neal DE; Horne CH
    Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer.
    Tuna B; Yörükoğlu K; Tüzel E; Güray M; Mungan U; Kirkali Z
    Pathol Res Pract; 2003; 199(5):323-8. PubMed ID: 12908522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Is protein p53 an independent prognostic factor in bladder carcinoma?].
    Keilholz L
    Strahlenther Onkol; 1995 Sep; 171(9):543-4. PubMed ID: 7570304
    [No Abstract]   [Full Text] [Related]  

  • 54. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
    Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
    J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.
    Ye D; Li H; Qian S; Sun Y; Zheng J; Ma Y
    J Urol; 1998 Dec; 160(6 Pt 1):2025-8; discussion 2029. PubMed ID: 9817315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.
    Rieger KM; Little AF; Swart JM; Kastrinakis WV; Fitzgerald JM; Hess DT; Libertino JA; Summerhayes IC
    Br J Cancer; 1995 Sep; 72(3):683-90. PubMed ID: 7669581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiogenin expression in superficial bladder cancer.
    Maeda K; Nomata K; Noguchi M; Kanetake H
    Hinyokika Kiyo; 2001 Aug; 47(8):547-52. PubMed ID: 11579593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications.
    Kuczyk MA; Serth J; Hervatin C; Arndt H; Derendorf L; Thon WF; Jonas U
    World J Urol; 1994; 12(6):345-51. PubMed ID: 7881474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].
    Cheng L; Xu JW; He JJ; Zhao J; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):714-7. PubMed ID: 22321559
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.
    Wu TT; Chen JH; Lee YH; Huang JK
    J Urol; 2000 Mar; 163(3):758-60. PubMed ID: 10687971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.